301 related articles for article (PubMed ID: 25790910)
1. Anti-diabetic effects of Ganoderma lucidum.
Ma HT; Hsieh JF; Chen ST
Phytochemistry; 2015 Jun; 114():109-13. PubMed ID: 25790910
[TBL] [Abstract][Full Text] [Related]
2. Preventive and Therapeutic Effect of Ganoderma (Lingzhi) on Diabetes.
Liu Q; Tie L
Adv Exp Med Biol; 2019; 1182():201-215. PubMed ID: 31777020
[TBL] [Abstract][Full Text] [Related]
3. Effect of a novel proteoglycan PTP1B inhibitor from Ganoderma lucidum on the amelioration of hyperglycaemia and dyslipidaemia in db/db mice.
Wang CD; Teng BS; He YM; Wu JS; Pan D; Pan LF; Zhang D; Fan ZH; Yang HJ; Zhou P
Br J Nutr; 2012 Dec; 108(11):2014-25. PubMed ID: 22453054
[TBL] [Abstract][Full Text] [Related]
4. Novel hypoglycemic effects of Ganoderma lucidum water-extract in obese/diabetic (+db/+db) mice.
Seto SW; Lam TY; Tam HL; Au AL; Chan SW; Wu JH; Yu PH; Leung GP; Ngai SM; Yeung JH; Leung PS; Lee SM; Kwan YW
Phytomedicine; 2009 May; 16(5):426-36. PubMed ID: 19109000
[TBL] [Abstract][Full Text] [Related]
5. Hypoglycemic effect and mechanism of a proteoglycan from ganoderma lucidum on streptozotocin-induced type 2 diabetic rats.
Teng BS; Wang CD; Zhang D; Wu JS; Pan D; Pan LF; Yang HJ; Zhou P
Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):166-75. PubMed ID: 22428467
[TBL] [Abstract][Full Text] [Related]
6. Hypoglycemic effects of Ganoderma lucidum polysaccharides in type 2 diabetic mice.
Xiao C; Wu QP; Cai W; Tan JB; Yang XB; Zhang JM
Arch Pharm Res; 2012 Oct; 35(10):1793-801. PubMed ID: 23139131
[TBL] [Abstract][Full Text] [Related]
7. Ganoderma lucidum: Multifaceted mechanisms to combat diabetes through polysaccharides and triterpenoids: A comprehensive review.
Ahmad MF; Ahmad FA; Hasan N; Alsayegh AA; Hakami O; Bantun F; Tasneem S; Alamier WM; Babalghith AO; Aldairi AF; Kambal N; Elbendary EY
Int J Biol Macromol; 2024 May; 268(Pt 1):131644. PubMed ID: 38642691
[TBL] [Abstract][Full Text] [Related]
8. A protein tyrosine phosphatase 1B activity inhibitor from the fruiting bodies of Ganoderma lucidum (Fr.) Karst and its hypoglycemic potency on streptozotocin-induced type 2 diabetic mice.
Teng BS; Wang CD; Yang HJ; Wu JS; Zhang D; Zheng M; Fan ZH; Pan D; Zhou P
J Agric Food Chem; 2011 Jun; 59(12):6492-500. PubMed ID: 21585203
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of ganoderma acids from Ganoderma lucidum as aldose reductase inhibitors.
Fatmawati S; Shimizu K; Kondo R
Bioorg Med Chem Lett; 2011 Dec; 21(24):7295-7. PubMed ID: 22047696
[TBL] [Abstract][Full Text] [Related]
10. Ganodermataceae: natural products and their related pharmacological functions.
Zhou X; Lin J; Yin Y; Zhao J; Sun X; Tang K
Am J Chin Med; 2007; 35(4):559-74. PubMed ID: 17708623
[TBL] [Abstract][Full Text] [Related]
11. Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera.
Jung HA; Islam MN; Lee CM; Oh SH; Lee S; Jung JH; Choi JS
Chem Biol Interact; 2013 Oct; 206(1):55-62. PubMed ID: 23994501
[TBL] [Abstract][Full Text] [Related]
12. Triterpenes and meroterpenes from Ganoderma lucidum with inhibitory activity against HMGs reductase, aldose reductase and α-glucosidase.
Chen B; Tian J; Zhang J; Wang K; Liu L; Yang B; Bao L; Liu H
Fitoterapia; 2017 Jul; 120():6-16. PubMed ID: 28527898
[TBL] [Abstract][Full Text] [Related]
13. Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities.
Xu Z; Chen X; Zhong Z; Chen L; Wang Y
Am J Chin Med; 2011; 39(1):15-27. PubMed ID: 21213395
[TBL] [Abstract][Full Text] [Related]
14. Ganoderol B: a potent α-glucosidase inhibitor isolated from the fruiting body of Ganoderma lucidum.
Fatmawati S; Shimizu K; Kondo R
Phytomedicine; 2011 Sep; 18(12):1053-5. PubMed ID: 21596546
[TBL] [Abstract][Full Text] [Related]
15. Ganoderma lucidum (Reishi) in cancer treatment.
Sliva D
Integr Cancer Ther; 2003 Dec; 2(4):358-64. PubMed ID: 14713328
[TBL] [Abstract][Full Text] [Related]
16. Ganoderma lucidum: a potent pharmacological macrofungus.
Sanodiya BS; Thakur GS; Baghel RK; Prasad GB; Bisen PS
Curr Pharm Biotechnol; 2009 Dec; 10(8):717-42. PubMed ID: 19939212
[TBL] [Abstract][Full Text] [Related]
17. Oral route of mini-proinsulin-expressing Ganoderma lucidum decreases blood glucose level in streptozocin-induced diabetic rats.
Ni T; Hu Y; Sun L; Chen X; Zhong J; Ma H; Lin Z
Int J Mol Med; 2007 Jul; 20(1):45-51. PubMed ID: 17549387
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of Ganoderma applanatum on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues.
Jung SH; Lee YS; Shim SH; Lee S; Shin KH; Kim JS; Kim YS; Kang SS
Phytother Res; 2005 Jun; 19(6):477-80. PubMed ID: 16114079
[TBL] [Abstract][Full Text] [Related]
19. Ganoderma lucidum and its pharmaceutically active compounds.
Boh B; Berovic M; Zhang J; Zhi-Bin L
Biotechnol Annu Rev; 2007; 13():265-301. PubMed ID: 17875480
[TBL] [Abstract][Full Text] [Related]
20. [Effects of medicinal insect Catharsius molossus on submerged fermentation and in vivo anti-hepatoma activity of Ganoderma lucidum].
Liu G; Ding C; Zhang K; Wang X
Sheng Wu Gong Cheng Xue Bao; 2009 Jun; 25(6):880-6. PubMed ID: 19777816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
